Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: Queen Mary University of London
Relapsing Remitting Multiple Sclerosis · Primary Progressive Multiple Sclerosis · Secondary Progressive Multiple Sclerosis
United Kingdom
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
- [18F]F-DED PET Imaging of Reactive Astrocytes in Multiple SclerosisNot Yet Recruiting
Sponsor: Parc de Salut Mar
Multiple Sclerosis
Spain
- Early Symptoms in Multiple Sclerosis: an Investigation Using fMRI and Gait Analysis to Develop Personalized Balance Training for People With Low DisabilityNot Yet Recruiting
Sponsor: LIFE - Research and Care Institute - Santa Lucia IRCCS
Multiple Sclerosis
Sponsor: Klinik Valens
Multiple Sclerosis · Balance
Switzerland
Sponsor: Novartis Pharmaceuticals
Progressive Multiple Sclerosis
Australia, Canada, France, Germany, Italy +2 more
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Central Nervous System Disease · Multiple Sclerosis
United States
Sponsor: Universidad de León
Multiple Sclerosis
Spain
- Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisEnrolling By Invitation
Sponsor: Accelerated Cure Project for Multiple Sclerosis
Multiple Sclerosis · Fatigue
United States
- Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Austria, Brazil, Bulgaria, Canada +12 more
- A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple SclerosisNot Yet Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Relapsing-remitting Multiple Sclerosis
Sponsor: Uppsala University
Relapsing-remitting Multiple Sclerosis
Sweden
Sponsor: Dokuz Eylul University
Kinesiophobia · Multiple Sclerosis
Turkey (Türkiye)
Sponsor: Region Stockholm
Multiple Sclerosis
Sweden
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Primary Progressive
United States, Argentina, Australia, Austria, Brazil +23 more
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Scleroderma, Diffuse
United States, Argentina, Australia, Austria, Belgium +17 more
- An Online Nurse-Led Purpose-Focused Group Program for Adult Women With Multiple Sclerosis: Effects on Meaning and Quality of LifeActive Not Recruiting
Sponsor: Texas Woman's University
Multiple Sclerosis
United States
Sponsor: Nantes University Hospital
Multiple Sclerosis (MS)
France
Sponsor: Casa di Cura San Raffaele Cassino
Neurodegenerative Diseases · Parkinson Disease · Synucleinopathies · Lewy Body Disease
Italy
Sponsor: SetPoint Medical Corporation
Relapsing Remitting Multiple Sclerosis
United States
- Traditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialActive Not Recruiting
Sponsor: Johns Hopkins University
Multiple Sclerosis, Relapsing-Remitting
United States
- An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Australia, France, Germany, Italy, Spain +1 more
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States